{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T21:20:05Z","timestamp":1775251205590,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,4]]},"DOI":"10.7759\/cureus.49904","type":"journal-article","created":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T14:30:45Z","timestamp":1701700245000},"source":"Crossref","is-referenced-by-count":4,"title":["Isotretinoin-Related Eye Dryness in Acne Patients in Qassim, Saudi Arabia"],"prefix":"10.7759","author":[{"given":"Yasmeen A","family":"Alfouzan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rana A","family":"Al-Hammad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferial A","family":"Alkhuzayem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raghad F","family":"Alkhudair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mzoun A","family":"Alotaibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah N","family":"Alajaji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed A","family":"Al-Muhaylib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Isotretinoin","author":"Pile HD","year":"2023","unstructured":"Pile HD, Sadiq NM. Isotretinoin. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61729-2","article-title":"Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Vos T","year":"2012","unstructured":"Vos T, Flaxman AD, Naghavi M, et al.. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012, 380:2163-96. 10.1016\/S0140-6736(12)61729-2","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12149","article-title":"Epidemiology of acne vulgaris","volume":"168","author":"Bhate K","year":"2013","unstructured":"Bhate K, Williams HC. Epidemiology of acne vulgaris. Br J Dermatol. 2013, 168:474-85. 10.1111\/bjd.12149","journal-title":"Br J Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsps.2023.101796","article-title":"Awareness of isotretinoin use and safety in Saudi Arabia: a nationwide cross-sectional study","volume":"31","author":"Alshehri AA","year":"2023","unstructured":"Alshehri AA, Althobaiti BA, Khawagi WY, Murphy KD. Awareness of isotretinoin use and safety in Saudi Arabia: a nationwide cross-sectional study. Saudi Pharm J. 2023, 31:101796. 10.1016\/j.jsps.2023.101796","journal-title":"Saudi Pharm J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.24628","article-title":"Patients\u2019 awareness of the ocular side effects of isotretinoin therapy: a study from Saudi Arabia","volume":"14","author":"AlMasoudi RM","year":"2022","unstructured":"AlMasoudi RM, Bahaj RK, Kokandi AA. Patients\u2019 awareness of the ocular side effects of isotretinoin therapy: a study from Saudi Arabia. Cureus. 2022, 14:e24628. 10.7759\/cureus.24628","journal-title":"Cureus"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9394(01)01024-8","article-title":"Ocular side effects possibly associated with isotretinoin usage","volume":"132","author":"Fraunfelder FT","year":"2001","unstructured":"Fraunfelder FT, Fraunfelder FW, Edwards R. Ocular side effects possibly associated with isotretinoin usage. Am J Ophthalmol. 2001, 132:299-305. 10.1016\/s0002-9394(01)01024-8","journal-title":"Am J Ophthalmol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.joco.2018.06.005","article-title":"Evaluation of the effects of isotretinoin for treatment of acne on corneal sensitivity","volume":"30","author":"Fouladgar N","year":"2018","unstructured":"Fouladgar N, Khabazkhoob M, Hanifnia AR, Yekta A, Mirzajani A. Evaluation of the effects of isotretinoin for treatment of acne on corneal sensitivity. J Curr Ophthalmol. 2018, 30:326-9. 10.1016\/j.joco.2018.06.005","journal-title":"J Curr Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S321591","article-title":"The relationship between dry eye disease and digital screen use","volume":"15","author":"Al-Mohtaseb Z","year":"2021","unstructured":"Al-Mohtaseb Z, Schachter S, Shen Lee B, Garlich J, Trattler W. The relationship between dry eye disease and digital screen use. Clin Ophthalmol. 2021, 15:3811-20. 10.2147\/OPTH.S321591","journal-title":"Clin Ophthalmol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14029","article-title":"Isotretinoin and the eye: a review for the dermatologist","volume":"33","author":"Ruiz-Lozano RE","year":"2020","unstructured":"Ruiz-Lozano RE, Hern\u00e1ndez-Camarena JC, Garza-Garza LA, Bustamante-Arias A, Colorado-Zavala MF, Cardenas-de la Garza JA. Isotretinoin and the eye: a review for the dermatologist. Dermatol Ther. 2020, 33:e14029. 10.1111\/dth.14029","journal-title":"Dermatol Ther"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.31080\/ASOP.2020.03.ASOP-03-0088","article-title":"Efficacy of thermo mechanical pulsations in management of meibomien gland dysfunction: a comparative study","volume":"3.2","author":"Radwan M","year":"2020","unstructured":"Radwan M, Sherif O, Othman T. Efficacy of thermo mechanical pulsations in management of meibomien gland dysfunction: a comparative study. Acta Sci Ophthalmol. 2020, 3.2:12-9. 10.31080\/ASOP.2020.03.ASOP-03-0088","journal-title":"Acta Sci Ophthalmol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4103\/2277-9175.129693","article-title":"Efficacy of fixed daily 20 mg of isotretinoin in moderate to severe scar prone acne","volume":"3","author":"Rasi A","year":"2014","unstructured":"Rasi A, Behrangi E, Rohaninasab M, Nahad ZM. Efficacy of fixed daily 20 mg of isotretinoin in moderate to severe scar prone acne. Adv Biomed Res. 2014, 3:103. 10.4103\/2277-9175.129693","journal-title":"Adv Biomed Res"},{"key":"ref12","article-title":"The use of isotretinoin in the treatment of acne vulgaris: clinical considerations and future directions","volume":"7","author":"Leyden JJ","year":"2014","unstructured":"Leyden JJ, Del Rosso JQ, Baum EW. The use of isotretinoin in the treatment of acne vulgaris: clinical considerations and future directions. J Clin Aesthet Dermatol. 2014, 7:S3-S21.","journal-title":"J Clin Aesthet Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4161\/derm.1.3.9364","article-title":"The use of isotretinoin in acne","volume":"1","author":"Layton A","year":"2009","unstructured":"Layton A. The use of isotretinoin in acne. Dermatoendocrinol. 2009, 1:162-9. 10.4161\/derm.1.3.9364","journal-title":"Dermatoendocrinol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.5114\/ada.2022.118921","article-title":"The use of isotretinoin in acne therapy in early childhood and its effect on the occurrence of acne symptoms later in life. Eight-year follow-up","volume":"39","author":"Brzezinski P","year":"2022","unstructured":"Brzezinski P, Wollina U, Smigielski J, Borowska K. The use of isotretinoin in acne therapy in early childhood and its effect on the occurrence of acne symptoms later in life. Eight-year follow-up. Postepy Dermatol Alergol. 2022, 39:682-7. 10.5114\/ada.2022.118921","journal-title":"Postepy Dermatol Alergol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s40123-023-00737-6","article-title":"The effect of oral isotretinoin therapy on meibomian gland characteristics in patients with acne vulgaris","volume":"12","author":"Zakrzewska A","year":"2023","unstructured":"Zakrzewska A, Wi\u0105cek MP, S\u0142uczanowska-G\u0142\u0105bowska S, Safranow K, Machali\u0144ska A. The effect of oral isotretinoin therapy on meibomian gland characteristics in patients with acne vulgaris. Ophthalmol Ther. 2023, 12:2187-97. 10.1007\/s40123-023-00737-6","journal-title":"Ophthalmol Ther"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/9443884","article-title":"Patients\u2019 knowledge and information needs about isotretinoin therapy use in Jordan","volume":"2022","author":"Jarab AS","year":"2022","unstructured":"Jarab AS, Al-Azzam S, Almutairi S, Mukattash TL. Patients\u2019 knowledge and information needs about isotretinoin therapy use in Jordan. Int J Clin Pract. 2022, 2022:9443884. 10.1155\/2022\/9443884","journal-title":"Int J Clin Pract"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S292569","article-title":"Dermatologists\u2019 knowledge and attitudes toward dry eye disease, refractive surgery, and contact lenses when prescribing isotretinoin in Saudi Arabia","volume":"14","author":"Basheikh A","year":"2020","unstructured":"Basheikh A, Alattas A, Alshareef R, Bamahfouz A. Dermatologists\u2019 knowledge and attitudes toward dry eye disease, refractive surgery, and contact lenses when prescribing isotretinoin in Saudi Arabia. Clin Ophthalmol. 2020, 14:4519-22. 10.2147\/OPTH.S292569","journal-title":"Clin Ophthalmol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.abd.2020.09.001","article-title":"Consensus on the use of oral isotretinoin in dermatology - Brazilian Society of Dermatology","volume":"95","author":"Bagatin E","year":"2020","unstructured":"Bagatin E, Costa CS, Rocha MA, et al.. Consensus on the use of oral isotretinoin in dermatology - Brazilian Society of Dermatology. An Bras Dermatol. 2020, 95:19-38. 10.1016\/j.abd.2020.09.001","journal-title":"An Bras Dermatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.2147\/OPTO.S337920","article-title":"OSDI outcomes based on patient demographic and wear patterns in prosthetic replacement of the ocular surface ecosystem","volume":"14","author":"Asghari B","year":"2022","unstructured":"Asghari B, Brocks D, Carrasquillo KG, Crowley E. OSDI outcomes based on patient demographic and wear patterns in prosthetic replacement of the ocular surface ecosystem. Clin Optom (Auckl). 2022, 14:1-12. 10.2147\/OPTO.S337920","journal-title":"Clin Optom (Auckl)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1080\/15569527.2022.2050747","article-title":"Ocular manifestations of systemic isotretinoin in patients with acne: a systemic review and meta-analysis","volume":"41","author":"Elubous KA","year":"2022","unstructured":"Elubous KA, Toubasi AA, Elubous A, Alryalat SA, Abous H. Ocular manifestations of systemic isotretinoin in patients with acne: a systemic review and meta-analysis. Cutan Ocul Toxicol. 2022, 41:113-22. 10.1080\/15569527.2022.2050747","journal-title":"Cutan Ocul Toxicol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadr.2021.100230","article-title":"Isotretinoin and neuropsychiatric side effects: continued vigilance is needed","volume":"6","author":"Bremner JD","year":"2021","unstructured":"Bremner JD. Isotretinoin and neuropsychiatric side effects: continued vigilance is needed. J Affect Disord Rep. 2021, 6:10.1016\/j.jadr.2021.100230","journal-title":"J Affect Disord Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/204602-isotretinoin-related-eye-dryness-in-acne-patients-in-qassim-saudi-arabia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:12:08Z","timestamp":1707509528000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/204602-isotretinoin-related-eye-dryness-in-acne-patients-in-qassim-saudi-arabia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,4]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.49904","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,4]]}}}